Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in GSK — GSK plc

CIK 72971 SAN FRANCISCO, CA
Back to GSK Full portfolio

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$71,355,518
-$6,213,914 QoQ
Shares Held
1,361,227
-3.1% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Derivatives in GSK

reported options exposure · as of Dec 31, 2024
CallValue
$811,680
CallShares
24,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. GSK ranks #13 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,646,119 $5,572,694,974
2 JNJ
Johnson & Johnson
 17,374,433 $4,412,584,747
3 AMGN
Amgen Inc
 7,235,462 $2,620,105,497
4 ABBV
AbbVie Inc.
 9,017,580 $2,269,183,828
5 MRK
Merck & Co., Inc.
 11,658,434 $1,498,108,767
6 GILD
Gilead Sciences, Inc.
 6,439,586 $813,577,293
7 PFE
Pfizer Inc
 20,193,675 $486,263,691
8 BMY
Bristol Myers Squibb Co
 6,321,643 $364,253,067

All Filings in GSK

Export CSV
41 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,355,518 1,361,227
2026-03-31 $77,569,432 1,405,498
2025-12-31 $124,358,082 2,535,850
2025-09-30 $122,746,478 2,843,987
2025-06-30 $108,229,669 2,818,481
2025-03-31 $55,503,571 1,432,720
2024-12-31 $48,820,284 1,443,533
2024-12-31 $811,680 24,000
2024-09-30 $64,358,568 1,574,329
2024-06-30 $66,569,425 1,729,076
2024-03-31 $81,741,084 1,906,720
2023-12-31 $214,948 5,800
2023-12-31 $1,326,748 35,800
2023-12-31 $91,578,111 2,471,077
2023-09-30 $89,909,206 2,480,254
2023-06-30 $117,612 3,300
2023-06-30 $82,983,711 2,328,387
2023-03-31 $82,271,846 2,312,306
2023-03-31 $149,436 4,200
2022-12-31 $93,656,251 2,665,232
2022-12-31 $80,822 2,300
2022-12-31 $1,054,200 30,000
2022-09-30 $80,201,310 2,725,155
2022-09-30 $765,180 26,000
2022-06-30 $153,502,042 3,595,382
2022-06-30 $1,097,240 25,700
2022-03-31 $147,162,116 3,444,512
2022-03-31 $1,102,269 25,800
2021-12-31 $155,654,364 3,598,672
2021-09-30 $132,235,175 3,528,495
2021-06-30 $156,688,769 4,011,956
2021-03-31 $145,470,540 4,155,737
2021-03-31 $15,314,578 437,500
2020-12-31 $2,487,000 413,600
2020-12-31 $168,401,954 4,665,722
2020-09-30 $228,337,669 6,185,111
2020-09-30 $2,471,000 405,800
2020-06-30 $232,792,553 5,818,820
2020-06-30 $2,012,000 453,800
2020-03-31 $1,839,000 254,400
2020-03-31 $220,595,853 5,935,978

Report a Problem

Category
Description
Email (optional, for follow-up)